Aurora Spine Corporation
ASG.VTSXVHealthcare● Active
$0.23
+$0.00(+0.00%)
Market Cap$17961206
P/E Ratio—
52W High$0.355
52W Low$0.205
Aurora Spine Corporation (ASG.V) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ASG.V · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($0.74M) | ($1.00M) | ($1.68M) | ($1.50M) | ($2.36M) |
| Depreciation & Amort. | $0.00M | $1.01M | $1.05M | $0.87M | $0.65M |
| Stock-Based Comp. | $0.00M | $0.10M | $0.14M | $0.14M | $0.14M |
| Change in Working Capital | $0.22M | $0.62M | ($0.62M) | ($1.36M) | ($0.74M) |
| Net Cash from Operations | $0.93M | $0.90M | ($0.94M) | ($1.56M) | ($2.13M) |
| Investing Activities | |||||
| Capital Expenditure | ($0.51M) | ($0.64M) | ($0.48M) | ($0.87M) | ($0.72M) |
| Purchases of Investments | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Sales of Investments | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Cash from Investing | ($0.55M) | ($0.48M) | ($0.48M) | ($0.87M) | ($0.72M) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Dividends Paid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Debt Issued / Repaid | ($0.37M) | ($0.36M) | ($0.32M) | ($0.42M) | ($0.21M) |
| Net Cash from Financing | ($0.31M) | ($0.36M) | $1.76M | ($0.32M) | $4.31M |
| Free Cash Flow | |||||
| Free Cash Flow | $0.42M | $0.27M | ($1.41M) | ($2.43M) | ($2.85M) |
| FCF Margin %(computed) | 2.29% | 1.52% | -9.74% | -16.34% | -27.03% |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · M
Explore more Aurora Spine Corporation data
About Aurora Spine Corporation (ASG.V) Cash Flow Statement
Aurora Spine Corporation generated operating cash flow of $0.00B and free cash flow of $0.00B for 2025 — a FCF margin of 2.29%. Capital expenditure was ($0.00B).
Frequently asked questions
ASG.V · 4 questionsAurora Spine Corporation generated free cash flow of $0.00B for 2025, up 57.6% year-over-year.
ASG.V free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10